Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Novo Nordisk

Novo Nordisk raises outlook on Wegovy pill sales

Shares of the Danish pharmaceutical firm climbed after it increased its financial targets, citing robust consumer adoption of its new oral weight-loss medication.

NVO-0.6%

Illustration for the Business desk

The stocks in this story

  1. NVO-0.6%Novo Nordisk A/S$40.19

Prices from Before the open · based on Tue close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.